Orpyx is Empowering People with Diabetes to Maintain Mobility.

Founded by Dr Breanne Everett, the company is revolutionizing diabetes care by providing patients with an in-shoe, plantar pressure sensor-based system plus mobile application that delivers targeted advice to manage diabetic foot ulcers (DFU).

The company’s flagship product, Orpyx® SI sensory insoles, empower people with diabetes to maintain mobility by helping prevent diabetic foot ulcers and limb loss through advanced pressure, temperature and movement sensor technology and analytics. In fact, the company’s clinically validated system, has demonstrated greater than a 70% reduction in ulceration and amputations in high risk diabetic patients.

The company has also developed the Kinetyx™ system which is used by researchers and practitioners to access clinical-grade data for advanced sports performance applications.

Orpyx SI sensory insoles are a patented, Class II Exempt system that is registered with the FDA and Health Canada.